The global sales of the Global In Vivo Toxicology Market in 2022 were held at US$ 5.2 Billion. With a projected CAGR of 5.6%, the market is expected to reach a valuation of US$ 9.5 Billion by the end of the forecast period.
Consumables are expected to be the highest revenue-generating type in this market, with a projected CAGR of over 5% from 2023 to 2033.
As per the research of the In Vivo Toxicology Market by Transparency Market Research-a market research and competitive intelligence provider, historically, from 2018 to 2022, the market value increased by around 4.4% CAGR. With an absolute dollar opportunity of US$ 4 Billion, the market is projected to reach a valuation of US$ 9.5 Billion by 2033.
In vivo toxicology refers to the study of the potential toxicity of a substance or compound on living organisms, typically animals. In vivo toxicology testing involves administering a substance to an animal and observing its effects on various organs and systems in the body. This testing can help to identify the potential adverse effects of a substance and to determine safe doses for use in humans.
The increasing demand for safety and efficacy testing in the pharmaceutical and biotechnological industries and advancement in technologies such as gene editing and gene therapy that require specialized toxicology testing are the driving factors for the outsourced in vivo toxicology testing market.
In the United States, the NIH's National Institute of Environmental Health Sciences (NIEHS) invested over US$ 78 million in research related to toxicology, including in vivo studies in the year 2021. Increasing investment from the government for research and development and drug discovery influences market growth in upcoming years.
In vivo toxicology testing has played a crucial role in the development of COVID-19 vaccines and treatments. Animal models have been used to test the safety and efficacy of vaccines and therapeutics before they are tested in humans. Mice are commonly used as animal models for studying the immune response to COVID-19. The increase in the use of in vivo toxicology testing influences market growth.
North America is a prominent market for in vivo toxicology with a market size of US$ 2.1 billion in 2022. It is projected that the region will have a market worth US$ 3.9 billion by 2033.
In 2019-2020, the Canadian Institutes of Health Research (CIHR), invested over US$ 300 million in health research across Canada. This includes research related to CRISPR-Cas9 gene editing technology.
CRISPR/Cas9 gene editing is a powerful tool that can be used in several applications, including in vivo toxicology testing. In vivo toxicology testing involves assessing the potential toxicity of a drug or other substance in living organisms, typically using animal models. The increase in investment by the government influences the growth of the in-vivo toxicology market.
The market in the United States is expected to grow to be worth US$ 3.4 Billion by 2033, with an absolute dollar growth of US$ 1.4 Billion from 2023 to 2033. The market in the United States has grown at a CAGR of 4% from 2018 to 2022 and is expected to grow at a CAGR of 5.4% from 2023 to 2033.
According to the American Cancer Society, in 2019, over 228 thousand cases of lung cancer were diagnosed while 142 thousand deaths were reported in the United States. In vivo toxicology testing may be used to evaluate the potential toxicity of chemotherapy drugs, targeted therapies, or other experimental treatments.
These testing involve the administration of a substance to laboratory animals, typically rodents such as mice or rats, to evaluate its effects on the animals' health and well-being. Due increase in lung cancer cases, increases the demand for new drug discovery which influences the in vivo toxicology testing market rise in the upcoming years.
The market in the United Kingdom is expected to grow to be worth US$ 364.9 million by 2033, with an absolute dollar growth of US$ 134.7 million. The market in the country has grown at a CAGR of 2.8% from 2018 to 2022 and is expected to grow at a CAGR of 4.7% from 2023 to 2033.
According to research, in the United Kingdom, over 4 thousand people were diagnosed with Hepatitis B in 2019, while over 113 thousand individuals were living with Hepatitis C in 2018. In vivo toxicology testing can be used to evaluate the safety and efficacy of antiviral medications used to treat hepatitis B and C. This is projected to influence market growth in the future.
In China, the market is expected to grow to be worth US$ 746.9 million with an absolute dollar growth of US$ 289.5 million by 2033. The market in China has grown at a CAGR of 3.5% from 2018 to 2022 and is expected to grow at a CAGR of 5% from 2023 to 2033.
According to ClinicalTrials.gov, in 2020, around 7 thousand clinical trials were registered in China. Clinical trials are an essential component of in vivo toxicology testing, as they are used to evaluate the safety and efficacy of new drugs and therapies in humans. In vivo toxicology studies, which involve the use of live animals to test the safety of drugs and chemicals, provide important information about the potential risks and side effects of a new treatment. Due to the increase in new drug development and research, the demand for in vivo toxicology has been on the surge.
In Japan, the market is expected to grow to be worth US$ 610.5 million with an absolute dollar growth of US$ 204.4 million by 2033. The market in Japan has grown at a CAGR of 2.2% from 2018 to 2022 and is expected to grow at a CAGR of 4.2% from 2023 to 2033.
According to the Ministry of Health, Labor, and Welfare, in Japan, about 180 thousand individuals were diagnosed with Parkinson’s disease in 2019. Due to the increase in the cases of Parkinson’s disease, there will be an increase in research and development of new drugs and treatments.
In Vivo Toxicology Testing can be used to evaluate the safety and efficacy of new drugs and treatments for Parkinson's disease as well as to assess potential side effects and toxicity. Animal models are often used in Parkinson's disease research to study the underlying mechanisms of the disease and to test potential new treatments.
The market in India is expected to grow to be worth US$ 373.5 million by 2033, with an absolute dollar growth of US$ 117.1 million. The market in the country has grown at a CAGR of 1.6% from 2018 to 2022 and is expected to grow at a CAGR of 3.8% from 2023 to 2033.
According to research, in 2020, there were around 2.3 million cases were diagnosed with HIV and about 69 thousand deaths were reported in India. The increase in the cases of infectious disease influences the demand for in vivo toxicology in the country.
Consumables are projected to witness the fastest growth as it has grown at a CAGR of 4.2% from 2018 to 2022 and is expected to grow at a CAGR of 5.4% from 2023 to 2033.
In vivo toxicology is the study of the adverse effects of chemicals or substances on living organisms. Consumables are products that are used or consumed relatively quickly and need to be replaced regularly, such as reagents, kits, and test systems, among others. The pharmaceutical industry is constantly developing new drugs, and in vivo toxicology testing is an important part of the drug development process. This has led to an increase in demand for consumables used in these tests.
The market through Academic and Research Institutes is projected to witness the fastest growth with a CAGR of 5.2% from 2023 to 2033.
Academic and research institutes are involved in extensive research activities, including drug development, toxicity testing, and basic research. In vivo toxicology testing is an important part of these research activities, and this has led to an increase in demand for in vivo toxicology testing.
Key players in the market are Charles River Laboratories, THE JACKSON LABORATORY, Envigo, Taconic Biosciences, Inc., genOway, Thermo Fisher Scientific, Danaher Corporation, Waters Corporation, Agilent Technologies, Shimadzu Corporation, Bruker Corporation, PerkinElmer, Merck KGaA, BioSpace, and Bio-Rad Laboratories.
A few of the recent developments in the In Vivo Toxicology Industry are:
By Product:
By Test Type:
By Testing Facility:
By Toxicity End Point:
By End User:
By Region:
|
Attributes |
Details |
|
Global In Vivo Toxicology Market Size 2022 |
US$ 5.2 Billion |
|
Global In Vivo Toxicology Industry Size (2033) |
US$ 9.5 Billion |
|
Global Market CAGR (2023 to 2033) |
5.6% |
|
U.S. In Vivo Toxicology Market CAGR (2023 to 2033) |
5.4% |
|
Key Companies Covered |
|
The global market size is estimated to be valued at US$ 5.5 Billion in 2023.
The market was reported at US$ 5.2 Billion in 2022.
The market is expected to reach a valuation of US$ 9.5 Billion in 2033.
The market registered a CAGR of 4.4% over the last 4 years.
The market is projected to witness a CAGR of 5.6% from 2023 to 2033.
Demand through consumables is projected to witness large demand till 2033 with expected growth at a CAGR of 5.4% by 2033.
Academic and research institutes are the end user of in vivo toxicology market is projected to witness large demand till 2033 with expected growth at a CAGR of 5.2% by 2033.
The market in the United States is projected to witness a market size of US$ 1.4 Billion and is expected to grow at a 5.4% CAGR from 2023 to 2033.
Key players in the market are Charles River Laboratories, THE JACKSON LABORATORY, Envigo, Taconic Biosciences, Inc., genOway , Thermo Fisher Scientific, Danaher Corporation, Waters Corporation, Agilent Technologies, Shimadzu Corporation, Bruker Corporation, PerkinElmer, Merck KGaA, BioSpace, and Bio-Rad Laboratories.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global In Vivo Toxicology Market Analysis 2018-2022 and Forecast, 2023-2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018-2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023-2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global In Vivo Toxicology Market Analysis 2018-2022 and Forecast 2023-2033, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2018-2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023-2033
5.3.1. Instruments
5.3.2. Consumables
5.3.2.1. Reagents & Kits
5.3.2.2. Animal Models
5.4. Y-o-Y Growth Trend Analysis By Product, 2018-2022
5.5. Absolute $ Opportunity Analysis By Product, 2023-2033
6. Global In Vivo Toxicology Market Analysis 2018-2022 and Forecast 2023-2033, By Test Type
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Test Type, 2018-2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Test Type, 2023-2033
6.3.1. Acute
6.3.2. Sub-acute
6.3.3. Sub-chronic
6.3.4. Chronic Test Type
6.4. Y-o-Y Growth Trend Analysis By Test Type, 2018-2022
6.5. Absolute $ Opportunity Analysis By Test Type, 2023-2033
7. Global In Vivo Toxicology Market Analysis 2018-2022 and Forecast 2023-2033, By Testing Facility
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By Testing Facility , 2018-2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Testing Facility , 2023-2033
7.3.1. Outsourced Testing Facility
7.3.2. In-house Testing Facility
7.4. Y-o-Y Growth Trend Analysis By Testing Facility , 2018-2022
7.5. Absolute $ Opportunity Analysis By Testing Facility , 2023-2033
8. Global In Vivo Toxicology Market Analysis 2018-2022 and Forecast 2023-2033, By Toxicity End Point
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Million) Analysis By Toxicity End Point, 2018-2022
8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Toxicity End Point, 2023-2033
8.3.1. Immunotoxicity
8.3.2. Systemic Toxicity
8.3.3. Carcinogenicity
8.3.4. Genotoxicity
8.3.5. Developmental & Reproductive Toxicity
8.3.6. Other Toxicity End Points
8.4. Y-o-Y Growth Trend Analysis By Toxicity End Point, 2018-2022
8.5. Absolute $ Opportunity Analysis By Toxicity End Point, 2023-2033
9. Global In Vivo Toxicology Market Analysis 2018-2022 and Forecast 2023-2033, By End User
9.1. Introduction / Key Findings
9.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018-2022
9.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023-2033
9.3.1. Academic and Research Institutes
9.3.2. Pharmaceutical & Biotechnology Companies
9.3.3. Contract Research Organizations
9.3.4. Others
9.4. Y-o-Y Growth Trend Analysis By End User, 2018-2022
9.5. Absolute $ Opportunity Analysis By End User, 2023-2033
10. Global In Vivo Toxicology Market Analysis 2018-2022 and Forecast 2023-2033, By Region
10.1. Introduction
10.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018-2022
10.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023-2033
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. Asia Pacific
10.3.5. Middle East and Africa
10.4. Market Attractiveness Analysis By Region
11. North America In Vivo Toxicology Market Analysis 2018-2022 and Forecast 2023-2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
11.2.1. By Country
11.2.1.1. U.S.
11.2.1.2. Canada
11.2.2. By Product
11.2.3. By Test Type
11.2.4. By Testing Facility
11.2.5. By Toxicity End Point
11.2.6. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product
11.3.3. By Test Type
11.3.4. By Testing Facility
11.3.5. By Toxicity End Point
11.3.6. By End User
11.4. Key Takeaways
12. Latin America In Vivo Toxicology Market Analysis 2018-2022 and Forecast 2023-2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
12.2.1. By Country
12.2.1.1. Brazil
12.2.1.2. Mexico
12.2.1.3. Rest of Latin America
12.2.2. By Product
12.2.3. By Test Type
12.2.4. By Testing Facility
12.2.5. By Toxicity End Point
12.2.6. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product
12.3.3. By Test Type
12.3.4. By Testing Facility
12.3.5. By Toxicity End Point
12.3.6. By End User
12.4. Key Takeaways
13. Europe In Vivo Toxicology Market Analysis 2018-2022 and Forecast 2023-2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
13.2.1. By Country
13.2.1.1. U.K.
13.2.1.2. Spain
13.2.1.3. Germany
13.2.1.4. Italy
13.2.1.5. France
13.2.1.6. Rest of Europe
13.2.2. By Product
13.2.3. By Test Type
13.2.4. By Testing Facility
13.2.5. By Toxicity End Point
13.2.6. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product
13.3.3. By Test Type
13.3.4. By Testing Facility
13.3.5. By Toxicity End Point
13.3.6. By End User
13.4. Key Takeaways
14. Asia Pacific In Vivo Toxicology Market Analysis 2018-2022 and Forecast 2023-2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. India
14.2.1.4. Rest of Asia Pacific
14.2.2. By Product
14.2.3. By Test Type
14.2.4. By Testing Facility
14.2.5. By Toxicity End Point
14.2.6. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product
14.3.3. By Test Type
14.3.4. By Testing Facility
14.3.5. By Toxicity End Point
14.3.6. By End User
14.4. Key Takeaways
15. Middle East and Africa In Vivo Toxicology Market Analysis 2018-2022 and Forecast 2023-2033, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
15.2.1. By Country
15.2.1.1. South Africa
15.2.1.2. GCC Countries
15.2.1.3. Rest of Middle East and Africa
15.2.2. By Product
15.2.3. By Test Type
15.2.4. By Testing Facility
15.2.5. By Toxicity End Point
15.2.6. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product
15.3.3. By Test Type
15.3.4. By Testing Facility
15.3.5. By Toxicity End Point
15.3.6. By End User
15.4. Key Takeaways
16. Key Countries In Vivo Toxicology Market Analysis
16.1. U.S.
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Product
16.1.2.2. By Test Type
16.1.2.3. By Testing Facility
16.1.2.4. By Toxicity End Point
16.1.2.5. By End User
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Product
16.2.2.2. By Test Type
16.2.2.3. By Testing Facility
16.2.2.4. By Toxicity End Point
16.2.2.5. By End User
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Product
16.3.2.2. By Test Type
16.3.2.3. By Testing Facility
16.3.2.4. By Toxicity End Point
16.3.2.5. By End User
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Product
16.4.2.2. By Test Type
16.4.2.3. By Testing Facility
16.4.2.4. By Toxicity End Point
16.4.2.5. By End User
16.5. U.K.
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Product
16.5.2.2. By Test Type
16.5.2.3. By Testing Facility
16.5.2.4. By Toxicity End Point
16.5.2.5. By End User
16.6. Spain
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Product
16.6.2.2. By Test Type
16.6.2.3. By Testing Facility
16.6.2.4. By Toxicity End Point
16.6.2.5. By End User
16.7. Germany
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Product
16.7.2.2. By Test Type
16.7.2.3. By Testing Facility
16.7.2.4. By Toxicity End Point
16.7.2.5. By End User
16.8. Italy
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Product
16.8.2.2. By Test Type
16.8.2.3. By Testing Facility
16.8.2.4. By Toxicity End Point
16.8.2.5. By End User
16.9. France
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Product
16.9.2.2. By Test Type
16.9.2.3. By Testing Facility
16.9.2.4. By Toxicity End Point
16.9.2.5. By End User
16.10. China
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Product
16.10.2.2. By Test Type
16.10.2.3. By Testing Facility
16.10.2.4. By Toxicity End Point
16.10.2.5. By End User
16.11. Japan
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Product
16.11.2.2. By Test Type
16.11.2.3. By Testing Facility
16.11.2.4. By Toxicity End Point
16.11.2.5. By End User
16.12. India
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Product
16.12.2.2. By Test Type
16.12.2.3. By Testing Facility
16.12.2.4. By Toxicity End Point
16.12.2.5. By End User
16.13. South Africa
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Product
16.13.2.2. By Test Type
16.13.2.3. By Testing Facility
16.13.2.4. By Toxicity End Point
16.13.2.5. By End User
16.14. GCC Countries
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Product
16.14.2.2. By Test Type
16.14.2.3. By Testing Facility
16.14.2.4. By Toxicity End Point
16.14.2.5. By End User
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Product
17.3.3. By Test Type
17.3.4. By Testing Facility
17.3.5. By Toxicity End Point
17.3.6. By End User
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Charles River Laboratories
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.2. THE JACKSON LABORATORY
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.3. Envigo
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.4. Taconic Biosciences, Inc.
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.5. genOway
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.6. Thermo Fisher Scientific
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.7. Danaher Corporation
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.8. Waters Corporation
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.9. Agilent Technologies
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.10. Shimadzu Corporation
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.11. Bruker Corporation
18.1.11.1. Overview
18.1.11.2. Product Portfolio
18.1.11.3. Profitability by Market Segments
18.1.11.4. Sales Footprint
18.1.11.5. Strategy Overview
18.1.11.5.1. Marketing Strategy
18.1.12. PerkinElmer
18.1.12.1. Overview
18.1.12.2. Product Portfolio
18.1.12.3. Profitability by Market Segments
18.1.12.4. Sales Footprint
18.1.12.5. Strategy Overview
18.1.12.5.1. Marketing Strategy
18.1.13. Merck KGaA
18.1.13.1. Overview
18.1.13.2. Product Portfolio
18.1.13.3. Profitability by Market Segments
18.1.13.4. Sales Footprint
18.1.13.5. Strategy Overview
18.1.13.5.1. Marketing Strategy
18.1.14. BioSpace
18.1.14.1. Overview
18.1.14.2. Product Portfolio
18.1.14.3. Profitability by Market Segments
18.1.14.4. Sales Footprint
18.1.14.5. Strategy Overview
18.1.14.5.1. Marketing Strategy
18.1.15. Bio-Rad Laboratories
18.1.15.1. Overview
18.1.15.2. Product Portfolio
18.1.15.3. Profitability by Market Segments
18.1.15.4. Sales Footprint
18.1.15.5. Strategy Overview
18.1.15.5.1. Marketing Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
List of Tables
Table 1: Global In Vivo Toxicology Market Value (US$ Million) Forecast by Region, 2018-2033
Table 2: Global In Vivo Toxicology Market Value (US$ Million) Forecast by Product, 2018-2033
Table 3: Global In Vivo Toxicology Market Value (US$ Million) Forecast by Test Type, 2018-2033
Table 4: Global In Vivo Toxicology Market Value (US$ Million) Forecast by Testing Facility , 2018-2033
Table 5: Global In Vivo Toxicology Market Value (US$ Million) Forecast by Toxicity End Point, 2018-2033
Table 6: Global In Vivo Toxicology Market Value (US$ Million) Forecast by End User, 2018-2033
Table 7: North America In Vivo Toxicology Market Value (US$ Million) Forecast by Country, 2018-2033
Table 8: North America In Vivo Toxicology Market Value (US$ Million) Forecast by Product, 2018-2033
Table 9: North America In Vivo Toxicology Market Value (US$ Million) Forecast by Test Type, 2018-2033
Table 10: North America In Vivo Toxicology Market Value (US$ Million) Forecast by Testing Facility , 2018-2033
Table 11: North America In Vivo Toxicology Market Value (US$ Million) Forecast by Toxicity End Point, 2018-2033
Table 12: North America In Vivo Toxicology Market Value (US$ Million) Forecast by End User, 2018-2033
Table 13: Latin America In Vivo Toxicology Market Value (US$ Million) Forecast by Country, 2018-2033
Table 14: Latin America In Vivo Toxicology Market Value (US$ Million) Forecast by Product, 2018-2033
Table 15: Latin America In Vivo Toxicology Market Value (US$ Million) Forecast by Test Type, 2018-2033
Table 16: Latin America In Vivo Toxicology Market Value (US$ Million) Forecast by Testing Facility , 2018-2033
Table 17: Latin America In Vivo Toxicology Market Value (US$ Million) Forecast by Toxicity End Point, 2018-2033
Table 18: Latin America In Vivo Toxicology Market Value (US$ Million) Forecast by End User, 2018-2033
Table 19: Europe In Vivo Toxicology Market Value (US$ Million) Forecast by Country, 2018-2033
Table 20: Europe In Vivo Toxicology Market Value (US$ Million) Forecast by Product, 2018-2033
Table 21: Europe In Vivo Toxicology Market Value (US$ Million) Forecast by Test Type, 2018-2033
Table 22: Europe In Vivo Toxicology Market Value (US$ Million) Forecast by Testing Facility , 2018-2033
Table 23: Europe In Vivo Toxicology Market Value (US$ Million) Forecast by Toxicity End Point, 2018-2033
Table 24: Europe In Vivo Toxicology Market Value (US$ Million) Forecast by End User, 2018-2033
Table 25: Asia Pacific In Vivo Toxicology Market Value (US$ Million) Forecast by Country, 2018-2033
Table 26: Asia Pacific In Vivo Toxicology Market Value (US$ Million) Forecast by Product, 2018-2033
Table 27: Asia Pacific In Vivo Toxicology Market Value (US$ Million) Forecast by Test Type, 2018-2033
Table 28: Asia Pacific In Vivo Toxicology Market Value (US$ Million) Forecast by Testing Facility , 2018-2033
Table 29: Asia Pacific In Vivo Toxicology Market Value (US$ Million) Forecast by Toxicity End Point, 2018-2033
Table 30: Asia Pacific In Vivo Toxicology Market Value (US$ Million) Forecast by End User, 2018-2033
Table 31: Middle East and Africa In Vivo Toxicology Market Value (US$ Million) Forecast by Country, 2018-2033
Table 32: Middle East and Africa In Vivo Toxicology Market Value (US$ Million) Forecast by Product, 2018-2033
Table 33: Middle East and Africa In Vivo Toxicology Market Value (US$ Million) Forecast by Test Type, 2018-2033
Table 34: Middle East and Africa In Vivo Toxicology Market Value (US$ Million) Forecast by Testing Facility , 2018-2033
Table 35: Middle East and Africa In Vivo Toxicology Market Value (US$ Million) Forecast by Toxicity End Point, 2018-2033
Table 36: Middle East and Africa In Vivo Toxicology Market Value (US$ Million) Forecast by End User, 2018-2033
List of Figure
Figure 1: Global In Vivo Toxicology Market Value (US$ Million) by Product, 2023-2033
Figure 2: Global In Vivo Toxicology Market Value (US$ Million) by Test Type, 2023-2033
Figure 3: Global In Vivo Toxicology Market Value (US$ Million) by Testing Facility , 2023-2033
Figure 4: Global In Vivo Toxicology Market Value (US$ Million) by Toxicity End Point, 2023-2033
Figure 5: Global In Vivo Toxicology Market Value (US$ Million) by End User, 2023-2033
Figure 6: Global In Vivo Toxicology Market Value (US$ Million) by Region, 2023-2033
Figure 7: Global In Vivo Toxicology Market Value (US$ Million) Analysis by Region, 2018-2033
Figure 8: Global In Vivo Toxicology Market Value Share (%) and BPS Analysis by Region, 2023-2033
Figure 9: Global In Vivo Toxicology Market Y-o-Y Growth (%) Projections by Region, 2023-2033
Figure 10: Global In Vivo Toxicology Market Value (US$ Million) Analysis by Product, 2018-2033
Figure 11: Global In Vivo Toxicology Market Value Share (%) and BPS Analysis by Product, 2023-2033
Figure 12: Global In Vivo Toxicology Market Y-o-Y Growth (%) Projections by Product, 2023-2033
Figure 13: Global In Vivo Toxicology Market Value (US$ Million) Analysis by Test Type, 2018-2033
Figure 14: Global In Vivo Toxicology Market Value Share (%) and BPS Analysis by Test Type, 2023-2033
Figure 15: Global In Vivo Toxicology Market Y-o-Y Growth (%) Projections by Test Type, 2023-2033
Figure 16: Global In Vivo Toxicology Market Value (US$ Million) Analysis by Testing Facility , 2018-2033
Figure 17: Global In Vivo Toxicology Market Value Share (%) and BPS Analysis by Testing Facility , 2023-2033
Figure 18: Global In Vivo Toxicology Market Y-o-Y Growth (%) Projections by Testing Facility , 2023-2033
Figure 19: Global In Vivo Toxicology Market Value (US$ Million) Analysis by Toxicity End Point, 2018-2033
Figure 20: Global In Vivo Toxicology Market Value Share (%) and BPS Analysis by Toxicity End Point, 2023-2033
Figure 21: Global In Vivo Toxicology Market Y-o-Y Growth (%) Projections by Toxicity End Point, 2023-2033
Figure 22: Global In Vivo Toxicology Market Value (US$ Million) Analysis by End User, 2018-2033
Figure 23: Global In Vivo Toxicology Market Value Share (%) and BPS Analysis by End User, 2023-2033
Figure 24: Global In Vivo Toxicology Market Y-o-Y Growth (%) Projections by End User, 2023-2033
Figure 25: Global In Vivo Toxicology Market Attractiveness by Product, 2023-2033
Figure 26: Global In Vivo Toxicology Market Attractiveness by Test Type, 2023-2033
Figure 27: Global In Vivo Toxicology Market Attractiveness by Testing Facility , 2023-2033
Figure 28: Global In Vivo Toxicology Market Attractiveness by Toxicity End Point, 2023-2033
Figure 29: Global In Vivo Toxicology Market Attractiveness by End User, 2023-2033
Figure 30: Global In Vivo Toxicology Market Attractiveness by Region, 2023-2033
Figure 31: North America In Vivo Toxicology Market Value (US$ Million) by Product, 2023-2033
Figure 32: North America In Vivo Toxicology Market Value (US$ Million) by Test Type, 2023-2033
Figure 33: North America In Vivo Toxicology Market Value (US$ Million) by Testing Facility , 2023-2033
Figure 34: North America In Vivo Toxicology Market Value (US$ Million) by Toxicity End Point, 2023-2033
Figure 35: North America In Vivo Toxicology Market Value (US$ Million) by End User, 2023-2033
Figure 36: North America In Vivo Toxicology Market Value (US$ Million) by Country, 2023-2033
Figure 37: North America In Vivo Toxicology Market Value (US$ Million) Analysis by Country, 2018-2033
Figure 38: North America In Vivo Toxicology Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 39: North America In Vivo Toxicology Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 40: North America In Vivo Toxicology Market Value (US$ Million) Analysis by Product, 2018-2033
Figure 41: North America In Vivo Toxicology Market Value Share (%) and BPS Analysis by Product, 2023-2033
Figure 42: North America In Vivo Toxicology Market Y-o-Y Growth (%) Projections by Product, 2023-2033
Figure 43: North America In Vivo Toxicology Market Value (US$ Million) Analysis by Test Type, 2018-2033
Figure 44: North America In Vivo Toxicology Market Value Share (%) and BPS Analysis by Test Type, 2023-2033
Figure 45: North America In Vivo Toxicology Market Y-o-Y Growth (%) Projections by Test Type, 2023-2033
Figure 46: North America In Vivo Toxicology Market Value (US$ Million) Analysis by Testing Facility , 2018-2033
Figure 47: North America In Vivo Toxicology Market Value Share (%) and BPS Analysis by Testing Facility , 2023-2033
Figure 48: North America In Vivo Toxicology Market Y-o-Y Growth (%) Projections by Testing Facility , 2023-2033
Figure 49: North America In Vivo Toxicology Market Value (US$ Million) Analysis by Toxicity End Point, 2018-2033
Figure 50: North America In Vivo Toxicology Market Value Share (%) and BPS Analysis by Toxicity End Point, 2023-2033
Figure 51: North America In Vivo Toxicology Market Y-o-Y Growth (%) Projections by Toxicity End Point, 2023-2033
Figure 52: North America In Vivo Toxicology Market Value (US$ Million) Analysis by End User, 2018-2033
Figure 53: North America In Vivo Toxicology Market Value Share (%) and BPS Analysis by End User, 2023-2033
Figure 54: North America In Vivo Toxicology Market Y-o-Y Growth (%) Projections by End User, 2023-2033
Figure 55: North America In Vivo Toxicology Market Attractiveness by Product, 2023-2033
Figure 56: North America In Vivo Toxicology Market Attractiveness by Test Type, 2023-2033
Figure 57: North America In Vivo Toxicology Market Attractiveness by Testing Facility , 2023-2033
Figure 58: North America In Vivo Toxicology Market Attractiveness by Toxicity End Point, 2023-2033
Figure 59: North America In Vivo Toxicology Market Attractiveness by End User, 2023-2033
Figure 60: North America In Vivo Toxicology Market Attractiveness by Country, 2023-2033
Figure 61: Latin America In Vivo Toxicology Market Value (US$ Million) by Product, 2023-2033
Figure 62: Latin America In Vivo Toxicology Market Value (US$ Million) by Test Type, 2023-2033
Figure 63: Latin America In Vivo Toxicology Market Value (US$ Million) by Testing Facility , 2023-2033
Figure 64: Latin America In Vivo Toxicology Market Value (US$ Million) by Toxicity End Point, 2023-2033
Figure 65: Latin America In Vivo Toxicology Market Value (US$ Million) by End User, 2023-2033
Figure 66: Latin America In Vivo Toxicology Market Value (US$ Million) by Country, 2023-2033
Figure 67: Latin America In Vivo Toxicology Market Value (US$ Million) Analysis by Country, 2018-2033
Figure 68: Latin America In Vivo Toxicology Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 69: Latin America In Vivo Toxicology Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 70: Latin America In Vivo Toxicology Market Value (US$ Million) Analysis by Product, 2018-2033
Figure 71: Latin America In Vivo Toxicology Market Value Share (%) and BPS Analysis by Product, 2023-2033
Figure 72: Latin America In Vivo Toxicology Market Y-o-Y Growth (%) Projections by Product, 2023-2033
Figure 73: Latin America In Vivo Toxicology Market Value (US$ Million) Analysis by Test Type, 2018-2033
Figure 74: Latin America In Vivo Toxicology Market Value Share (%) and BPS Analysis by Test Type, 2023-2033
Figure 75: Latin America In Vivo Toxicology Market Y-o-Y Growth (%) Projections by Test Type, 2023-2033
Figure 76: Latin America In Vivo Toxicology Market Value (US$ Million) Analysis by Testing Facility , 2018-2033
Figure 77: Latin America In Vivo Toxicology Market Value Share (%) and BPS Analysis by Testing Facility , 2023-2033
Figure 78: Latin America In Vivo Toxicology Market Y-o-Y Growth (%) Projections by Testing Facility , 2023-2033
Figure 79: Latin America In Vivo Toxicology Market Value (US$ Million) Analysis by Toxicity End Point, 2018-2033
Figure 80: Latin America In Vivo Toxicology Market Value Share (%) and BPS Analysis by Toxicity End Point, 2023-2033
Figure 81: Latin America In Vivo Toxicology Market Y-o-Y Growth (%) Projections by Toxicity End Point, 2023-2033
Figure 82: Latin America In Vivo Toxicology Market Value (US$ Million) Analysis by End User, 2018-2033
Figure 83: Latin America In Vivo Toxicology Market Value Share (%) and BPS Analysis by End User, 2023-2033
Figure 84: Latin America In Vivo Toxicology Market Y-o-Y Growth (%) Projections by End User, 2023-2033
Figure 85: Latin America In Vivo Toxicology Market Attractiveness by Product, 2023-2033
Figure 86: Latin America In Vivo Toxicology Market Attractiveness by Test Type, 2023-2033
Figure 87: Latin America In Vivo Toxicology Market Attractiveness by Testing Facility , 2023-2033
Figure 88: Latin America In Vivo Toxicology Market Attractiveness by Toxicity End Point, 2023-2033
Figure 89: Latin America In Vivo Toxicology Market Attractiveness by End User, 2023-2033
Figure 90: Latin America In Vivo Toxicology Market Attractiveness by Country, 2023-2033
Figure 91: Europe In Vivo Toxicology Market Value (US$ Million) by Product, 2023-2033
Figure 92: Europe In Vivo Toxicology Market Value (US$ Million) by Test Type, 2023-2033
Figure 93: Europe In Vivo Toxicology Market Value (US$ Million) by Testing Facility , 2023-2033
Figure 94: Europe In Vivo Toxicology Market Value (US$ Million) by Toxicity End Point, 2023-2033
Figure 95: Europe In Vivo Toxicology Market Value (US$ Million) by End User, 2023-2033
Figure 96: Europe In Vivo Toxicology Market Value (US$ Million) by Country, 2023-2033
Figure 97: Europe In Vivo Toxicology Market Value (US$ Million) Analysis by Country, 2018-2033
Figure 98: Europe In Vivo Toxicology Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 99: Europe In Vivo Toxicology Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 100: Europe In Vivo Toxicology Market Value (US$ Million) Analysis by Product, 2018-2033
Figure 101: Europe In Vivo Toxicology Market Value Share (%) and BPS Analysis by Product, 2023-2033
Figure 102: Europe In Vivo Toxicology Market Y-o-Y Growth (%) Projections by Product, 2023-2033
Figure 103: Europe In Vivo Toxicology Market Value (US$ Million) Analysis by Test Type, 2018-2033
Figure 104: Europe In Vivo Toxicology Market Value Share (%) and BPS Analysis by Test Type, 2023-2033
Figure 105: Europe In Vivo Toxicology Market Y-o-Y Growth (%) Projections by Test Type, 2023-2033
Figure 106: Europe In Vivo Toxicology Market Value (US$ Million) Analysis by Testing Facility , 2018-2033
Figure 107: Europe In Vivo Toxicology Market Value Share (%) and BPS Analysis by Testing Facility , 2023-2033
Figure 108: Europe In Vivo Toxicology Market Y-o-Y Growth (%) Projections by Testing Facility , 2023-2033
Figure 109: Europe In Vivo Toxicology Market Value (US$ Million) Analysis by Toxicity End Point, 2018-2033
Figure 110: Europe In Vivo Toxicology Market Value Share (%) and BPS Analysis by Toxicity End Point, 2023-2033
Figure 111: Europe In Vivo Toxicology Market Y-o-Y Growth (%) Projections by Toxicity End Point, 2023-2033
Figure 112: Europe In Vivo Toxicology Market Value (US$ Million) Analysis by End User, 2018-2033
Figure 113: Europe In Vivo Toxicology Market Value Share (%) and BPS Analysis by End User, 2023-2033
Figure 114: Europe In Vivo Toxicology Market Y-o-Y Growth (%) Projections by End User, 2023-2033
Figure 115: Europe In Vivo Toxicology Market Attractiveness by Product, 2023-2033
Figure 116: Europe In Vivo Toxicology Market Attractiveness by Test Type, 2023-2033
Figure 117: Europe In Vivo Toxicology Market Attractiveness by Testing Facility , 2023-2033
Figure 118: Europe In Vivo Toxicology Market Attractiveness by Toxicity End Point, 2023-2033
Figure 119: Europe In Vivo Toxicology Market Attractiveness by End User, 2023-2033
Figure 120: Europe In Vivo Toxicology Market Attractiveness by Country, 2023-2033
Figure 121: Asia Pacific In Vivo Toxicology Market Value (US$ Million) by Product, 2023-2033
Figure 122: Asia Pacific In Vivo Toxicology Market Value (US$ Million) by Test Type, 2023-2033
Figure 123: Asia Pacific In Vivo Toxicology Market Value (US$ Million) by Testing Facility , 2023-2033
Figure 124: Asia Pacific In Vivo Toxicology Market Value (US$ Million) by Toxicity End Point, 2023-2033
Figure 125: Asia Pacific In Vivo Toxicology Market Value (US$ Million) by End User, 2023-2033
Figure 126: Asia Pacific In Vivo Toxicology Market Value (US$ Million) by Country, 2023-2033
Figure 127: Asia Pacific In Vivo Toxicology Market Value (US$ Million) Analysis by Country, 2018-2033
Figure 128: Asia Pacific In Vivo Toxicology Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 129: Asia Pacific In Vivo Toxicology Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 130: Asia Pacific In Vivo Toxicology Market Value (US$ Million) Analysis by Product, 2018-2033
Figure 131: Asia Pacific In Vivo Toxicology Market Value Share (%) and BPS Analysis by Product, 2023-2033
Figure 132: Asia Pacific In Vivo Toxicology Market Y-o-Y Growth (%) Projections by Product, 2023-2033
Figure 133: Asia Pacific In Vivo Toxicology Market Value (US$ Million) Analysis by Test Type, 2018-2033
Figure 134: Asia Pacific In Vivo Toxicology Market Value Share (%) and BPS Analysis by Test Type, 2023-2033
Figure 135: Asia Pacific In Vivo Toxicology Market Y-o-Y Growth (%) Projections by Test Type, 2023-2033
Figure 136: Asia Pacific In Vivo Toxicology Market Value (US$ Million) Analysis by Testing Facility , 2018-2033
Figure 137: Asia Pacific In Vivo Toxicology Market Value Share (%) and BPS Analysis by Testing Facility , 2023-2033
Figure 138: Asia Pacific In Vivo Toxicology Market Y-o-Y Growth (%) Projections by Testing Facility , 2023-2033
Figure 139: Asia Pacific In Vivo Toxicology Market Value (US$ Million) Analysis by Toxicity End Point, 2018-2033
Figure 140: Asia Pacific In Vivo Toxicology Market Value Share (%) and BPS Analysis by Toxicity End Point, 2023-2033
Figure 141: Asia Pacific In Vivo Toxicology Market Y-o-Y Growth (%) Projections by Toxicity End Point, 2023-2033
Figure 142: Asia Pacific In Vivo Toxicology Market Value (US$ Million) Analysis by End User, 2018-2033
Figure 143: Asia Pacific In Vivo Toxicology Market Value Share (%) and BPS Analysis by End User, 2023-2033
Figure 144: Asia Pacific In Vivo Toxicology Market Y-o-Y Growth (%) Projections by End User, 2023-2033
Figure 145: Asia Pacific In Vivo Toxicology Market Attractiveness by Product, 2023-2033
Figure 146: Asia Pacific In Vivo Toxicology Market Attractiveness by Test Type, 2023-2033
Figure 147: Asia Pacific In Vivo Toxicology Market Attractiveness by Testing Facility , 2023-2033
Figure 148: Asia Pacific In Vivo Toxicology Market Attractiveness by Toxicity End Point, 2023-2033
Figure 149: Asia Pacific In Vivo Toxicology Market Attractiveness by End User, 2023-2033
Figure 150: Asia Pacific In Vivo Toxicology Market Attractiveness by Country, 2023-2033
Figure 151: Middle East and Africa In Vivo Toxicology Market Value (US$ Million) by Product, 2023-2033
Figure 152: Middle East and Africa In Vivo Toxicology Market Value (US$ Million) by Test Type, 2023-2033
Figure 153: Middle East and Africa In Vivo Toxicology Market Value (US$ Million) by Testing Facility , 2023-2033
Figure 154: Middle East and Africa In Vivo Toxicology Market Value (US$ Million) by Toxicity End Point, 2023-2033
Figure 155: Middle East and Africa In Vivo Toxicology Market Value (US$ Million) by End User, 2023-2033
Figure 156: Middle East and Africa In Vivo Toxicology Market Value (US$ Million) by Country, 2023-2033
Figure 157: Middle East and Africa In Vivo Toxicology Market Value (US$ Million) Analysis by Country, 2018-2033
Figure 158: Middle East and Africa In Vivo Toxicology Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 159: Middle East and Africa In Vivo Toxicology Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 160: Middle East and Africa In Vivo Toxicology Market Value (US$ Million) Analysis by Product, 2018-2033
Figure 161: Middle East and Africa In Vivo Toxicology Market Value Share (%) and BPS Analysis by Product, 2023-2033
Figure 162: Middle East and Africa In Vivo Toxicology Market Y-o-Y Growth (%) Projections by Product, 2023-2033
Figure 163: Middle East and Africa In Vivo Toxicology Market Value (US$ Million) Analysis by Test Type, 2018-2033
Figure 164: Middle East and Africa In Vivo Toxicology Market Value Share (%) and BPS Analysis by Test Type, 2023-2033
Figure 165: Middle East and Africa In Vivo Toxicology Market Y-o-Y Growth (%) Projections by Test Type, 2023-2033
Figure 166: Middle East and Africa In Vivo Toxicology Market Value (US$ Million) Analysis by Testing Facility , 2018-2033
Figure 167: Middle East and Africa In Vivo Toxicology Market Value Share (%) and BPS Analysis by Testing Facility , 2023-2033
Figure 168: Middle East and Africa In Vivo Toxicology Market Y-o-Y Growth (%) Projections by Testing Facility , 2023-2033
Figure 169: Middle East and Africa In Vivo Toxicology Market Value (US$ Million) Analysis by Toxicity End Point, 2018-2033
Figure 170: Middle East and Africa In Vivo Toxicology Market Value Share (%) and BPS Analysis by Toxicity End Point, 2023-2033
Figure 171: Middle East and Africa In Vivo Toxicology Market Y-o-Y Growth (%) Projections by Toxicity End Point, 2023-2033
Figure 172: Middle East and Africa In Vivo Toxicology Market Value (US$ Million) Analysis by End User, 2018-2033
Figure 173: Middle East and Africa In Vivo Toxicology Market Value Share (%) and BPS Analysis by End User, 2023-2033
Figure 174: Middle East and Africa In Vivo Toxicology Market Y-o-Y Growth (%) Projections by End User, 2023-2033
Figure 175: Middle East and Africa In Vivo Toxicology Market Attractiveness by Product, 2023-2033
Figure 176: Middle East and Africa In Vivo Toxicology Market Attractiveness by Test Type, 2023-2033
Figure 177: Middle East and Africa In Vivo Toxicology Market Attractiveness by Testing Facility , 2023-2033
Figure 178: Middle East and Africa In Vivo Toxicology Market Attractiveness by Toxicity End Point, 2023-2033
Figure 179: Middle East and Africa In Vivo Toxicology Market Attractiveness by End User, 2023-2033
Figure 180: Middle East and Africa In Vivo Toxicology Market Attractiveness by Country, 2023-2033
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
In Vivo Toxicology Market
*86 figures and 60 tables includes